| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 01/13/2010 | CN101627054A Methods of treating autoimmune disease using humanized anti-CD16A antibodies |
| 01/13/2010 | CN100579985C Streptococcus agalactiae antigens I and II |
| 01/13/2010 | CN100579581C Compositions for the treatment of mycobacterial infections |
| 01/12/2010 | US7645861 Modified Fc molecules |
| 01/12/2010 | US7645743 Administering immunity linkers with more than one binding site, wherein second site binds to target and individual has pre-existing cellular or humoral immune response to first site; high speed response to public health needs such as pandemic infections; biological warfare; vaccines |
| 01/12/2010 | US7645592 Glycoprotein VI antibodies and methods of use thereof |
| 01/12/2010 | US7645451 Treating a subject at risk of a tumor characterized by aberrant Dkk-1 expression using e.g. antibody, antisense agent |
| 01/12/2010 | US7645441 Compositions and methods in cancer associated with altered expression of PRLR |
| 01/12/2010 | CA2438143C Modified proteins, designer toxins, and methods of making thereof |
| 01/12/2010 | CA2351558C Peptide fragments having cell death inhibitory activity |
| 01/12/2010 | CA2309604C Compositions and methods for targeted delivery of factors |
| 01/12/2010 | CA2290217C Peptides for the detection of hiv-1 group o |
| 01/12/2010 | CA2272845C Viral material and nucleotide fragments associated with multiple sclerosis, for diagnostic, prophylactic and therapeutic purposes |
| 01/12/2010 | CA2255106C Varicella zoster virus (vzv) immunoreactive protein vp26 and its diagnostic use |
| 01/12/2010 | CA2201781C Chronic rheumatoid arthritis therapy containing il-6 antagonist as effective component |
| 01/12/2010 | CA2191655C Novel antibody compositions for preparing enriched human hematopoietic and tumor cell preparations |
| 01/12/2010 | CA2158782C Marker for growth hormone-releasing factor receptors |
| 01/07/2010 | WO2010003118A1 Tgf-b antagonist multi-target binding proteins |
| 01/07/2010 | WO2010003108A2 TNF-α ANTAGONIST MULTI-TARGET BINDING PROTEINS |
| 01/07/2010 | WO2010003101A2 Il6 immunotherapeutics |
| 01/07/2010 | WO2010003085A1 Fusion proteins and their use in the diagnosis and treatment of leishmaniasis |
| 01/07/2010 | WO2010002911A2 Methods and materials for monitoring myeloma using quantitative mass spetrometry |
| 01/07/2010 | WO2010002862A2 Fibroblast growth factor receptor 3 (fgfr3) binding proteins |
| 01/07/2010 | WO2010002822A1 Anti-gd2 antibodies and methods and uses related thereto |
| 01/07/2010 | WO2010002478A2 Glycopeptide and uses thereof |
| 01/07/2010 | WO2010002251A1 Vaccine against amyloid folding intermediate |
| 01/07/2010 | WO2010001908A1 Anti-cd27 antibody |
| 01/07/2010 | WO2010001891A1 Antibody complex, antigen detection method, and method for production of antibody complex |
| 01/07/2010 | WO2010001600A1 Positive affect marker gene and use thereof |
| 01/07/2010 | WO2010001585A1 Anti-cdh3 antibodies labeled with radioisotope label and uses thereof |
| 01/07/2010 | WO2010001251A2 Antigen binding polypeptides |
| 01/07/2010 | WO2010001079A1 Use of the irap protein for implementing methods of diagnosis and of prognosis |
| 01/07/2010 | WO2010000875A1 Erythropoietin receptor antibody and uses thereof |
| 01/07/2010 | WO2010000864A1 Method for producing monoclonal antibodies |
| 01/07/2010 | WO2010000849A2 A method for the screening of conserved secreted proteins |
| 01/07/2010 | WO2010000758A1 Method for optimizing proteins having the folding pattern of immunoglobulin |
| 01/07/2010 | WO2010000756A1 Detection of shed cd31, diagnosis of atherothrombosis and autoimmune disorders, and methods for analyzing signaling pathways |
| 01/07/2010 | WO2010000721A1 Anti-human interleukin-20 antibodies |
| 01/07/2010 | WO2010000565A1 Method for diagnosing cancers expressing the her2 receptor or its truncated variants |
| 01/07/2010 | WO2010000041A1 Anti- p2x7 peptides and epitopes |
| 01/07/2010 | WO2010000025A1 Anti-pamp therapeutic antibodies |
| 01/07/2010 | WO2009140348A3 Anti-il-6/il-6r antibodies and methods of use thereof |
| 01/07/2010 | WO2009138473A3 Intracellular antibody delivery |
| 01/07/2010 | WO2009137677A3 Reagents, methods, and systems for detecting methicillin-resistant staphylococcus |
| 01/07/2010 | WO2009121948A3 Single domain antibodies capable of modulating bace activity |
| 01/07/2010 | WO2009120903A3 Cytokine receptors associated with myelogenous haematological proliferative disorders and uses thereof |
| 01/07/2010 | WO2009120899A3 G coupled protein receptors associated with myelogenous haematological proliferative disorders and uses thereof |
| 01/07/2010 | WO2009115756A3 Method for direct detection of ischaemia-modified albumin using a partner for binding to an aldehyde derivative resulting from the peroxidation of lipids in bound form |
| 01/07/2010 | WO2009112502A9 Agent for treating disease |
| 01/07/2010 | WO2005114190A3 Methods of identifying biomarkers |
| 01/07/2010 | US20100005546 Compositions and methods for the improvement of plants |
| 01/07/2010 | US20100005543 Toxin genes and methods for their use |
| 01/07/2010 | US20100004871 Identities, specificities, and use of twenty two (22) differentially expressed protein biomarkers for blood based diagnosis of breast cancer |
| 01/07/2010 | US20100004431 Human equivalent monoclonal antibodies engineered from nonhuman variable regions |
| 01/07/2010 | US20100004430 Peptide-based immunization therapy for treatment of atherosclerosis |
| 01/07/2010 | US20100004429 Agonist antibody to human thrombopoietin receptor |
| 01/07/2010 | US20100004276 Vitamin receptor binding drug delivery conjugates |
| 01/07/2010 | US20100004176 Axmi-115, axmi-113, axmi-005, axmi-163 and axmi-184: insecticidal proteins and methods for their use |
| 01/07/2010 | US20100004167 Csf3r polypeptides and uses thereof |
| 01/07/2010 | US20100004162 Lynx, a novel family of receptor ligands in the central nervous system, corresponding nucleic acids and proteins and uses thereof |
| 01/07/2010 | US20100004139 Constructs and libraries comprising antibody surrogate light chain sequences |
| 01/07/2010 | US20100003749 Enriched Pancreatic Stem Cell and Progenitor Cell, Populations, and Methods For Identifying, Isolating and Enriching For Such Populations |
| 01/07/2010 | US20100003719 Trimerising Module |
| 01/07/2010 | US20100003705 Cln101 Antibody Compositions and Methods of Use Alone and in Combination with Prostate Specific Antigen and Other Cancer Markers |
| 01/07/2010 | US20100003694 Biomarkers and Uses Thereof |
| 01/07/2010 | US20100003682 Compositions, kits, and methods for identification, assessment, prevention and therapy of breast and ovarian cancer |
| 01/07/2010 | US20100003283 Lipid a deficient mutants of neisseria meningitidis |
| 01/07/2010 | US20100003281 antigenic determinant comprising a polypeptide sequence from hepatitis E virus open reading frame 2 ; drug screening |
| 01/07/2010 | US20100003273 Nucleic acid vaccines for prevention of flavivirus infection |
| 01/07/2010 | US20100003266 Targeted immune conjugates |
| 01/07/2010 | US20100003263 Monoclonal antibodies to anthrax protective antigen |
| 01/07/2010 | US20100003261 agonist anti-trk-c monoclonal antibodies |
| 01/07/2010 | US20100003259 Antibodies that immunospecifically bind to b lymphocyte stimulator protein |
| 01/07/2010 | US20100003258 Fibroblast growth factor receptor 3 (fgfr3) binding proteins |
| 01/07/2010 | US20100003255 Gene expression pattern predictive for colorectal carcinomas |
| 01/07/2010 | US20100003254 Antibody Substituting for Function of Blood Coagulation Factor VIII |
| 01/07/2010 | US20100003253 Single domain antibodies directed against epidermal growth factor receptor and uses therefor |
| 01/07/2010 | US20100003252 Blocking immune response to a graft |
| 01/07/2010 | US20100003251 Uses of IL-23 Agonists and Antagonists; Related Reagents |
| 01/07/2010 | US20100003249 Polypeptide constructs for topical administration |
| 01/07/2010 | US20100003248 Polypeptide constructs for rectal and/or vaginal administration |
| 01/07/2010 | US20100003245 Remedy for Renal Disease |
| 01/07/2010 | US20100003242 antibody that binds sphingosine-1-phosphate (S1P); used for detection of S1P or for treatment of diseases and conditions associated with S1P |
| 01/07/2010 | US20100003239 Anti-hedgehog antibodies |
| 01/07/2010 | US20100003234 Cellulase activity; used to make bioethanol, in food and textile treatment, in waste treatment; breaks down lignocellulose |
| 01/07/2010 | US20100003229 Nuclear telomerase reverse transcriptase variant |
| 01/07/2010 | CA2731981A1 Antibody complex, method for detecting antigen, and method for producing antibody complex |
| 01/07/2010 | CA2729868A1 Anti- p2x7 peptides and epitopes |
| 01/07/2010 | CA2729810A1 Tgf-.beta. antagonist multi-target binding proteins |
| 01/07/2010 | CA2729749A1 Tnf-a antagonist multi-target binding proteins |
| 01/07/2010 | CA2729747A1 Il6 immunotherapeutics |
| 01/07/2010 | CA2729591A1 Method for optimizing proteins having the folding pattern of immunoglobulin |
| 01/07/2010 | CA2729584A1 Detection of shed cd31, diagnosis of atherothrombosis and autoimmune disorders, and methods for analyzing signaling pathways |
| 01/07/2010 | CA2729567A1 Anti-cd27 antibody |
| 01/07/2010 | CA2729499A1 Anti-gd2 antibodies and methods and uses related thereto |
| 01/07/2010 | CA2729414A1 Vaccine against amyloid folding intermediate |
| 01/07/2010 | CA2729403A1 Anti-cdh3 antibodies labeled with radioisotope label and uses thereof |
| 01/07/2010 | CA2728685A1 Anti-human interleukin-20 antibodies |
| 01/07/2010 | CA2728180A1 Use of the irap protein for implementing methods of diagnosis and of prognosis |
| 01/07/2010 | CA2728076A1 Antigen binding polypeptides |